Copyright Reports & Markets. All rights reserved.

Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Overview

    • 1.1 Product Overview and Scope of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment
    • 1.2 Classification of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Types
      • 1.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Types in 2018
      • 1.2.3 Delafloxacin
      • 1.2.4 Vancomycin
      • 1.2.5 Ceftaroline Fosamil
      • 1.2.6 Others
    • 1.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Application
      • 1.3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Cellulitis
      • 1.3.3 Abscess
      • 1.3.4 Surgical Wounds
      • 1.3.5 Traumatic Wound
    • 1.4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Regions
      • 1.4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment (2014-2024)

    2 Company Profiles

    • 2.1 Paratek Pharmaceuticals, Inc.
      • 2.1.1 Business Overview
      • 2.1.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Cempra, Inc.
      • 2.2.1 Business Overview
      • 2.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Debiopharm International S.A.
      • 2.3.1 Business Overview
      • 2.3.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 GlaxoSmithKline plc
      • 2.4.1 Business Overview
      • 2.4.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Furiex Pharmaceuticals, Inc.
      • 2.5.1 Business Overview
      • 2.5.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Melinta Therapeutics, Inc.
      • 2.6.1 Business Overview
      • 2.6.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Actelion Pharmaceuticals Ltd.
      • 2.7.1 Business Overview
      • 2.7.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Durata Therapeutics, Inc.
      • 2.8.1 Business Overview
      • 2.8.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 MerLion Pharmaceuticals Pte Ltd.
      • 2.9.1 Business Overview
      • 2.9.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Abbott Laboratories, Inc.
      • 2.10.1 Business Overview
      • 2.10.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Macrolide Pharmaceuticals, Inc.
      • 2.11.1 Business Overview
      • 2.11.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Sanofi
      • 2.12.1 Business Overview
      • 2.12.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Albany Molecular Research, Inc.
      • 2.13.1 Business Overview
      • 2.13.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Zavante Therapeutics, Inc.
      • 2.14.1 Business Overview
      • 2.14.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Merck & Co, Inc.
      • 2.15.1 Business Overview
      • 2.15.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Bayer AG
      • 2.16.1 Business Overview
      • 2.16.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Allergan plc.
      • 2.17.1 Business Overview
      • 2.17.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Teva Pharmaceuticals Industries Ltd.
      • 2.18.1 Business Overview
      • 2.18.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Pfizer, Inc.
      • 2.19.1 Business Overview
      • 2.19.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 AstraZeneca
      • 2.20.1 Business Overview
      • 2.20.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Competition, by Players

    • 3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players Market Share
      • 3.2.2 Top 10 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions

    • 4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Market Share by Regions
    • 4.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 4.5 South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)

    5 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries

    • 5.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019)
    • 5.2 USA Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries

    • 6.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019)
    • 6.2 Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 6.3 UK Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 6.4 France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries

    • 7.1 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019)
    • 7.2 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 7.5 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)

    8 South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries

    • 8.1 South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019)
    • 8.2 Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Countries

    • 9.1 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019)

    10 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Segment by Type

    • 10.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Type (2019-2024)
    • 10.3 Delafloxacin Revenue Growth Rate (2014-2024)
    • 10.4 Vancomycin Revenue Growth Rate (2014-2024)
    • 10.5 Ceftaroline Fosamil Revenue Growth Rate (2014-2024)
    • 10.6 Others Revenue Growth Rate (2014-2024)

    11 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Segment by Application

    • 11.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Application (2014-2019)
    • 11.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Application (2019-2024)
    • 11.3 Cellulitis Revenue Growth (2014-2019)
    • 11.4 Abscess Revenue Growth (2014-2019)
    • 11.5 Surgical Wounds Revenue Growth (2014-2019)
    • 11.6 Traumatic Wound Revenue Growth (2014-2019)

    12 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Forecast (2019-2024)

    • 12.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Forecast (2019-2024)
    • 12.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Regions (2019-2024)
    • 12.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024)
    • 12.4 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024)
    • 12.6 South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      The global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Paratek Pharmaceuticals, Inc.
      Cempra, Inc.
      Debiopharm International S.A.
      GlaxoSmithKline plc
      Furiex Pharmaceuticals, Inc.
      Melinta Therapeutics, Inc.
      Actelion Pharmaceuticals Ltd.
      Durata Therapeutics, Inc.
      MerLion Pharmaceuticals Pte Ltd.
      Abbott Laboratories, Inc.
      Macrolide Pharmaceuticals, Inc.
      Sanofi
      Albany Molecular Research, Inc.
      Zavante Therapeutics, Inc.
      Merck & Co, Inc.
      Bayer AG
      Allergan plc.
      Teva Pharmaceuticals Industries Ltd.
      Pfizer, Inc.
      AstraZeneca

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Delafloxacin
      Vancomycin
      Ceftaroline Fosamil
      Others

      Market Segment by Applications, can be divided into
      Cellulitis
      Abscess
      Surgical Wounds
      Traumatic Wound
      Buy now